Management of first trimester of pregnancy by ayurveda

A controlled clinical study for evaluation of the effect of rasayana drugs and micronized progesterone during first trimester of pregnancy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/02/006628

Enrollment

Registered

2016-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- complaints of first trimester of pregnancy

Interventions

Intervention1: Group A: Rasayana drugs in the form of granules 10 gms BD for 2 months. Control Intervention1: Group B: Micronized progesteron 200mg BD for 2 months

Eligibility

Inclusion criteria

Inclusion criteria: 1. Elderly primigravida 2. Pregnancy after infertility 3. History of threatened abortion. 4. History of habitual abortion. 5. Delayed fetal pole development 6. Choriodecidual hemorrhage 7. History of Blightened ovum, IUFD, Congenital deformity, previous preterm birth, 8. Successful pregnancy after IVF and ET

Exclusion criteria

Exclusion criteria: 1. Pregnancy with uterine malformation and congenital defect of uterus. 2. Pregnancy with uterine fibroid and carcinoma. 3. Pregnancy with sexually transmitted disease 4. Severe PIH.

Design outcomes

Primary

Measure	Time frame
Relief in complaints of first trimester of pregnancyTimepoint: 60 days	—

Secondary

Measure	Time frame
continuation of pregnancy and fetal well being.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDR S B DONGA

IPGT AND RA, G.A.U. JAMNAGAR

deilaxmipriya@yahoo.com9228198366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026